340B OPERATIONS AND COMPLIANCE
strategic and technical experience
Polsinelli Healthcare Solutions provides turn-key 340B consulting solutions that recognize the value and complexities of the Federal 340B Program, which provides covered entities with substantial outpatient drug discounts to promote the treatment of vulnerable patient populations and expand access to care.
Our team helps covered entities navigate the 340B program’s complexities by developing and implementing custom-tailored practical and operationally feasible solutions that consider patient care, financial and risk-related objectives, and anticipate growing compliance trends. Polsinelli Healthcare Solutions advisors also help clients identify additional opportunities through partnerships with multiple 340B contract pharmacies. We strive to provide complete solutions so covered entities can rest assured during a time of intense government and manufacturer scrutiny.
340B Operations and Compliance Solutions
Polsinelli Healthcare Solutions’ advisors tailor our 340B offerings to meet each client’s needs through a range of services including:
340B program strategy including eligibility and feasibility assessments, financial analysis, contract pharmacy revenue opportunities and other strategies to enhance patient access to 340B drugs
Program development and implementation including software platform contracting and implementation, pharmacy leadership and staffing planning, selection and training on pharmacy, business and compliance
Design, implementation and oversight of contract pharmacy networks
340B program management and oversight including database and annual recertification management, development and implementation of action plans for transactions with 340B implications, including changes to provider-based sites, changes of ownership, mergers, acquisitions and other transactions
Independent audits of 340B programs, on-site support during Office of Pharmacy Affairs 340B audits, and develop, implement, monitor, and report on corrective action plans based on audit results
340B regulatory monitoring and public policy strategies